 |
|
|
|
|
|
|
| Article 1 to 10 out of 85 concerning Merck KGaA
|
-
EMD Chemicals Announces Price Increase for Specialty Chemical Products
(08/26/2008)
EMD Chemicals Inc. (EMD) announced that as of September 1, 2008, it will raise the prices of its specialty chemical products by 5 to 15% worldwide.Due to the sharp increase in the costs of raw materials, energy and logistic services, EMD Chemicals ...
-
Merck acquires LITEC-LLL GmbH
(07/09/2008)
A further step to strengthen activities in innovative lighting materials
Merck KGaA announced that it has acquired in full LITEC-LLL GmbH of Greifswald, Germany, a specialist in the research and development as well as production and marketing of ortho-silicate lighting materials. The acquisition of the company, which was ...
-
Merck Cooperates With the University of Applied Science in Muenster
(05/16/2008)
Scientists working in the Merck Lab in Muenster are developing novel LEDs
The newly established Merck Lab at the University of Applied Science in Muenster is now fully operational. Under the leadership of Professor Thomas Juestel, five experts from the university are developing novel light sources that are not only as ...
-
Merck Announces Executive Board Changes
(04/14/2008)
Walter Zywottek to retire on July 1; Dr. Bernd Reckmann to head the Chemicals business sector
Merck KGaA announced that Walter Zywottek (60), General Partner and Member of the Executive Board with responsibility for the Chemicals business sector, will retire on July 1, 2008. Dr. Bernd Reckmann (53) has been appointed to succeed him in this ...
-
Merck: Personnel Change on the Supervisory Board
(12/10/2007)
Merck KGaA announced that Heiner Wilhelm (53) has become a member of the Supervisory Board representing the employees.Wilhelm is succeeding Flavio Battisti, who has retired. Wilhelm was elected as a replacement member during the most recent ...
-
Paul Schmidt Joins EMD Crop BioScience as President
(12/10/2007)
Paul Schmidt has joined EMD Crop BioScience as President, succeeding Tom Winkofske, who will retire at the end of the year. To aid in the transition, Winkofske will temporarily serve in a consultant role.Schmidt brings 25 years of experience in the ...
-
Merck Submits European Marketing Authorization Application for Sapropterin as a Treatment for Hyperphenylalaninemia
(11/12/2007)
Sapropterin has been granted Orphan Medicinal Product designation for the treatment of hyperphenylalaninemia
Merck KGaA announced that its division Merck Serono has submitted an application to the European Medicines Agency (EMEA) for the marketing authorization (MA) of sapropterin (INN: sapropterin dihydrochloride, formerly known as Phenoptin(TM)) as an ...
-
Merck Names New Managers for Chemicals Divisions
(10/12/2007)
Merck announced that it has realigned the leadership of its Chemicals divisions. The current Head of Liquid Crystals, Dr. Paul Breddels (51), has decided to leave the company for personal reasons. As of November 1, 2007, Walter Galinat, currently ...
-
Merck Successfully Replaces EUR 2 billion Multi-Currency Revolving Credit Facility
(10/08/2007)
Merck KGaA announced that it has successfully completed the syndication of a new EUR 2 billion multi-currency revolving credit facility. The credit facility will be used for general corporate purposes and has a seven-year tenor. The facility will ...
-
Merck Completes Sale of Generics Business to Mylan for EUR 4.9 Billion
(10/05/2007)
Merck KGaA announced that it has completed the sale of its worldwide Generics business to Mylan Laboratories Inc. Closing was accomplished via a purchase agreement whereby Mylan acquired all Merck Generics companies throughout the world for EUR 4.9 ...
Additional information
Merck KGaA
Darmstadt, Germany
Company
|
|
|
|
|
|
Top
